elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40456936-3ED5AE25-2632-452B-AC9D-B1DA7AC572CE
Q40456936-3ED5AE25-2632-452B-AC9D-B1DA7AC572CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40456936-3ED5AE25-2632-452B-AC9D-B1DA7AC572CE
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis.
P2860
Q40456936-3ED5AE25-2632-452B-AC9D-B1DA7AC572CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40456936-3ED5AE25-2632-452B-AC9D-B1DA7AC572CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
893f663ac7b59e19a158f0a59c55f48a444f9b96
P2860
Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.